Sonim Technologies (SONM) Stock Forecast, Price & News

Sonim Technologies' stock was trading at $0.4248 on January 1st, 2023. Since then, SONM shares have increased by 144.8% and is now trading at $1.04.
View the best growth stocks for 2023 here.

Sonim Technologies saw a increase in short interest in May. As of May 15th, there was short interest totaling 101,100 shares, an increase of 152.1% from the April 30th total of 40,100 shares. Based on an average daily trading volume, of 287,300 shares, the short-interest ratio is currently 0.4 days. Approximately 0.5% of the company's stock are sold short.
View Sonim Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our SONM earnings forecast.

Sonim Technologies, Inc. (NASDAQ:SONM) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($1.31) earnings per share for the quarter, missing the consensus estimate of ($0.70) by $0.61. The business earned $14.45 million during the quarter, compared to analyst estimates of $16.10 million. Sonim Technologies had a negative trailing twelve-month return on equity of 38.87% and a negative net margin of 8.07%.

Sonim Technologies's stock reverse split on the morning of Thursday, September 16th 2021. The 1-10 reverse split was announced on Thursday, September 16th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 16th 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Sonim Technologies issued an update on its first quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $25.80 million-$25.80 million.

51 employees have rated Sonim Technologies Chief Executive Officer Bob Plaschke on Glassdoor.com. Bob Plaschke has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sonim Technologies investors own include TherapeuticsMD (TXMD), Acasti Pharma (ACST), Outlook Therapeutics (OTLK), Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), electroCore (ECOR), Heat Biologics (HTBX), Matinas BioPharma (MTNB) and NIO (NIO).

(SONM) raised $50 million in an IPO on Friday, May 10th 2019. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. Oppenheimer and Lake Street acted as the underwriters for the IPO and National Securities Corporation was co-manager.

Sonim Technologies trades on the NASDAQ under the ticker symbol "SONM."

Sonim Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Sicart Associates LLC (0.49%). Insiders that own company stock include Ajp Holding Company, Llc, Alan B Howe, Brc Partners Opportunity Fund,, Hao Peter Liu, Jeffrey Wang, Maurice Hochschild, Robert L Tirva, Robert L Tirva and Thomas Wiley Wilkinson.
View institutional ownership trends.

Shares of SONM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SONM stock can currently be purchased for approximately $1.04.

Sonim Technologies (NASDAQ:SONM) has a market capitalization of $42.63 million and generates $69.83 million in revenue each year.

Sonim Technologies' mailing address is 6836 Bee Cave Road Bldg. 1 S#279, Austin TX, 78746. The official website for the company is www.sonimtech.com. The company can be reached via phone at (650) 378-8100 or via email at sonm@gatewayir.com.